Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |